| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2013 | WO2013055252A1 Salts of carbamoyl phosphonic acid esters which act as selective inhibitors of human immunodeficiency virus hiv-1 production |
| 04/18/2013 | WO2013055251A1 Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases |
| 04/18/2013 | WO2013055245A1 Prevention and reduction of uncontrolled decrease of blood glucose levels in diabetic patients |
| 04/18/2013 | WO2013055197A1 Base powder from the red raspberry rubus idaeus and activated micronized zeolite for attenuating nicotine addiction, method for the preparation thereof and use thereof |
| 04/18/2013 | WO2013054998A1 Novel chalcone derivative and anticancer composition comprising same as active ingredient |
| 04/18/2013 | WO2013054940A1 Therapeutic agent and preventive agent for demyelinating disease |
| 04/18/2013 | WO2013054872A1 TABLET INCLUDING 7-[4-(4-BENZO[ｂ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR SALT THEREOF |
| 04/18/2013 | WO2013054866A1 Agent for preventing or treating htlv-i associated myelopathy |
| 04/18/2013 | WO2013054862A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | WO2013054822A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013054809A1 External preparation for skin |
| 04/18/2013 | WO2013054770A1 Anemia of cancer improving / prophylactic agent |
| 04/18/2013 | WO2013054765A1 Improving / prophylactic agent for chronic kidney disease |
| 04/18/2013 | WO2013054756A1 Treatment agent and/or prophylactic agent for side effects of cancer drugs |
| 04/18/2013 | WO2013054755A1 Erythropoietin production-promoting agent |
| 04/18/2013 | WO2013054582A1 Orally dispersible tablet |
| 04/18/2013 | WO2013054534A1 DRUGS FOR DISEASES ASSOCIATED WITH AMYLOID β, AND SCREENING THEREFOR |
| 04/18/2013 | WO2013054470A1 Enhancer of survival of transplanted organ |
| 04/18/2013 | WO2013054352A1 Pharmaceutical compositions of ibuprofen and famotidine |
| 04/18/2013 | WO2013054351A1 Heterocyclic compounds |
| 04/18/2013 | WO2013054345A2 Pharmaceutical combination |
| 04/18/2013 | WO2013054338A1 2-thio-imidazole derivatives as tgr5 modulators |
| 04/18/2013 | WO2013054337A1 Extended release pharmaceutical compositions of fesoterodine |
| 04/18/2013 | WO2013054330A1 Foam formulations |
| 04/18/2013 | WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | WO2013054275A1 Sila analogs of oxazolidinone derivatives and synthesis thereof |
| 04/18/2013 | WO2013054267A1 Synergistic composition for preventing and treating disorders connected with ageing |
| 04/18/2013 | WO2013054204A2 A process for making an intermediate of cabazitaxel |
| 04/18/2013 | WO2013054185A1 Pyrimidine and pyridine derivatives useful in therapy |
| 04/18/2013 | WO2013054153A1 Nutlin compounds for use in he treatment of pulmonary hypertension |
| 04/18/2013 | WO2013054146A1 New co crystals useful in the preparation of pharmaceutical compositions |
| 04/18/2013 | WO2013054137A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | WO2013054135A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | WO2013054113A1 Targeting of mirna precursors |
| 04/18/2013 | WO2013054111A1 Improved sperm function/activity |
| 04/18/2013 | WO2013054108A1 Mono-fluoro beta-secretase inhibitors |
| 04/18/2013 | WO2013054070A1 Anti-inflammatory compounds |
| 04/18/2013 | WO2013053983A1 Protein kinase inhibitors |
| 04/18/2013 | WO2013053954A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013053942A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances |
| 04/18/2013 | WO2013053928A1 Tricyclo-phosphorothioate dna |
| 04/18/2013 | WO2013053904A1 Stent |
| 04/18/2013 | WO2013053881A1 Inhibitor of colonisation of mucosa |
| 04/18/2013 | WO2013053873A1 Pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053872A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053871A1 Pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053856A1 Prevention and treatment of ocular conditions |
| 04/18/2013 | WO2013053838A1 Method for preparing glucans from aspergillus niger |
| 04/18/2013 | WO2013053833A1 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases |
| 04/18/2013 | WO2013053830A1 Use of a composition comprising a poly-organosiloxane |
| 04/18/2013 | WO2013053795A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/18/2013 | WO2013053751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | WO2013053746A1 Composition for the prophylactic treatment of neuropathic pain |
| 04/18/2013 | WO2013053739A1 Process for preparing factor xa inhibitors |
| 04/18/2013 | WO2013053725A1 2-oxo-piperidinyl derivatives |
| 04/18/2013 | WO2013053690A1 Pde9i with imidazo pyrazinone backbone |
| 04/18/2013 | WO2013053658A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/18/2013 | WO2013053657A1 Antiviral compounds |
| 04/18/2013 | WO2013053485A1 Formulations containing quetiapine |
| 04/18/2013 | WO2013053481A1 Dimethyl sulfoxide as solvent for nucleic acids |
| 04/18/2013 | WO2013053480A1 Composition for introducing nucleic acids into cells |
| 04/18/2013 | WO2013053457A1 Synthesis of an injectable multiphasic gel containing free and cross-linked monophasic hyaluronic acid and biphasic hyaluronic acid combined with hydroxyapatite with microencapsulated hyaluronidase inhibitor. |
| 04/18/2013 | WO2013053422A1 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters |
| 04/18/2013 | WO2013053372A1 Boronic acid inhibitors of beta-lactamases |
| 04/18/2013 | WO2013053287A1 Derivative of butylphthalide and preparation method and use thereof |
| 04/18/2013 | WO2013053273A1 Imidazo quinoline derivative and medicinal salt thereof, preparation method thereof and use in medicine thereof |
| 04/18/2013 | WO2013053206A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| 04/18/2013 | WO2013053072A1 Gastrointestinal tract function improvement-based composition aiding reductions in blood sugar and in blood lipids |
| 04/18/2013 | WO2013053051A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | WO2013053045A1 Heterocyclic molecules as apoptosis inducers |
| 04/18/2013 | WO2013053015A1 Meloxicam based formulations for providing analgesia in sheep |
| 04/18/2013 | WO2013036567A3 Methods, compositions, and compounds for the reduction of illegal methamphetamine production |
| 04/18/2013 | WO2013028570A3 Meta-substituted biphenyl peripherally restricted faah inhibitors |
| 04/18/2013 | WO2013027196A9 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 04/18/2013 | WO2013024291A3 Therapeutically active fused pyrimidine derivatives |
| 04/18/2013 | WO2013023000A9 Small molecule compounds that control mammal-pathogenic nematodes |
| 04/18/2013 | WO2013022927A3 Treatment of uterine leiomyomata |
| 04/18/2013 | WO2013020184A9 Flavonoid compounds, and methods of use thereof |
| 04/18/2013 | WO2013006761A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same |
| 04/18/2013 | WO2012178036A3 Inhibitors of rtt109 as anti-fungal agents |
| 04/18/2013 | WO2012158030A3 Drug delivery system |
| 04/18/2013 | WO2012145491A3 Composition and method for enhancing an immune response |
| 04/18/2013 | WO2012094302A3 Drug delivery using fine fiber encapsulation |
| 04/18/2013 | WO2012065102A8 S-t-butyl protected cysteine di-peptide analogs and related compounds |
| 04/18/2013 | WO2012054718A8 Treating long qt syndrome |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096204 Buffered Oxygen Therapeutic |
| 04/18/2013 | US20130096200 Treprostinil treatment for interstitial lung disease and asthma |
| 04/18/2013 | US20130096199 Bromfenac bioavailability |
| 04/18/2013 | US20130096198 Tranexamic Acid Formulations |
| 04/18/2013 | US20130096197 Methods of treating hypertriglyceridemia |
| 04/18/2013 | US20130096196 Pharmaceutical semi-solid composition of isotretinoin |
| 04/18/2013 | US20130096195 Therapeutic treatment |
| 04/18/2013 | US20130096191 Benzonatate Compositions and Methods of Use |
| 04/18/2013 | US20130096190 Perfluorocarbon gel formulations |
| 04/18/2013 | US20130096188 Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 04/18/2013 | US20130096187 Pharmaceutical composition for external use |
| 04/18/2013 | US20130096181 Methods of using scd1 antagonists |
| 04/18/2013 | US20130096180 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same |
| 04/18/2013 | US20130096173 Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence |